← Back to Search

Vitamin

NR plus Walking Exercise for High Blood Pressure

Phase 1
Waitlist Available
Led By Robert Mankowski, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; week 3; week 6
Awards & highlights

Study Summary

This trial suggests that nicotinamide riboside may help hypertensive older adults by enhancing the effects of exercise therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; week 3; week 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; week 3; week 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in SBP
Secondary outcome measures
Arterial Stiffness

Trial Design

3Treatment groups
Active Control
Group I: NR plus Walking ExerciseActive Control2 Interventions
1,000 mg/day of NR combined with three days/week of supervised, center-based walking exercise (n=18)
Group II: NR AloneActive Control1 Intervention
1,000 mg/day of NR
Group III: Walking Exercise plus PlaceboActive Control1 Intervention
1,000 mg/day of Placebo combined with three days/week of supervised, center-based walking exercise (n=18)

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,014 Total Patients Enrolled
University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,656 Total Patients Enrolled
Robert Mankowski, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies open for participants in this examination?

"Indeed, clinicaltrials.gov reveals that this research venture is currently recruiting subjects. Launched on July 28th 2020 and revised as recently as September 15th 2022, the trial seeks 74 volunteers from a single location."

Answered by AI

What is the size of the cohort participating in this clinical trial?

"Affirmative. Clinicaltrials.gov confirms that this medical experiment, initially posted on July 28th 2020 is actively looking for patients to join the study. Currently 74 participants need to be recruited from 1 clinical site."

Answered by AI

Have any experiments been conducted to explore the possible benefits of NR Alone?

"Currently, there are 15 active studies being conducted on the effectiveness of NR Alone. One such study is in its final phase. While Winston-Salem, North carolina houses many of these trials, 19 other sites across the USA have projects related to this treatment underway as well."

Answered by AI

Are there significant risks associated with NR Alone?

"Due to its current status as a Phase 1 investigation, the safety of NR Alone was assigned an estimated rating of one. This reflects limited data supporting both efficacy and safety outcomes."

Answered by AI

Does this experiment permit persons under the age of seventy to take part?

"For this medical trial, individuals aged between 55 and 105 years are eligible for enrollment."

Answered by AI

Are there any eligibility criteria for my participation in this medical research?

"For this hypertension clinical trial, 74 individuals aged between 55 and 105 are being sought. In addition to age requirements, participants must have daytime average systolic BP of at least 130 mmHg but not exceeding 160 mmHg., be inactive with less than 150 minutes per week of moderate physical activity as reported on the CHAMPS questionnaire., consent to randomization into either treatment group and agree to complete all study procedures."

Answered by AI
~10 spots leftby Apr 2025